| Literature DB >> 29539432 |
Shiho Fujisaka1, Julian Avila-Pacheco2, Marion Soto3, Aleksandar Kostic4, Jonathan M Dreyfuss5, Hui Pan5, Siegfried Ussar6, Emrah Altindis3, Ning Li7, Lynn Bry7, Clary B Clish2, C Ronald Kahn8.
Abstract
Diet, genetics, and the gut microbiome are determinants of metabolic status, in part through production of metabolites by the gut microbiota. To understand the mechanisms linking these factors, we performed LC-MS-based metabolomic analysis of cecal contents and plasma from C57BL/6J, 129S1/SvImJ, and 129S6/SvEvTac mice on chow or a high-fat diet (HFD) and HFD-treated with vancomycin or metronidazole. Prediction of the functional metagenome of gut bacteria by PICRUSt analysis of 16S sequences revealed dramatic differences in microbial metabolism. Cecal and plasma metabolites showed multifold differences reflecting the combined and integrated effects of diet, antibiotics, host background, and the gut microbiome. Eighteen plasma metabolites correlated positively or negatively with host insulin resistance across strains and diets. Over 1,000 still-unidentified metabolite peaks were also highly regulated by diet, antibiotics, and genetic background. Thus, diet, host genetics, and the gut microbiota interact to create distinct responses in plasma metabolites, which can contribute to regulation of metabolism and insulin resistance.Entities:
Keywords: TMAO; antibiotics; bile acids; cecal metabolomics; diabetes; diet; gut microbiome; obesity; serum lipids; serum metabolomics
Mesh:
Year: 2018 PMID: 29539432 PMCID: PMC5880543 DOI: 10.1016/j.celrep.2018.02.060
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423